会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Cyclic triazo and diazo sodium channel blockers
    • 环状三唑和重氮钠通道阻滞剂
    • US08691818B2
    • 2014-04-08
    • US12811884
    • 2009-01-16
    • Michael LeachLaurence HarbigeDieter RiddallKarl Franzmann
    • Michael LeachLaurence HarbigeDieter RiddallKarl Franzmann
    • A61K31/53C07D253/06C07D253/08
    • C07D253/075C07D253/06C07D253/07C07D253/10C07D401/04C07D405/04C07D405/12C07D405/14C07D409/04C07D409/12
    • Compounds of general structure in which X and Y are each N or C with at least one of X and Y being N; Z is a single bond or an optionally substituted linking group R1 is hydrogen or a substituent group; R2 is amino or a substituent group; N* is amino when RI is hydrogen or ═NH when R1 is a substituent group; or N* is a group NRaRb where Ra and Rb are independently H or an alkyl group; or N* is an optionally substituted piperazinyl ring; and A is an optionally substituted heterocyclic or carbocyclic ring system which may be linked to the triazo/diazo ring through R2 to form a fused multicyclic ring; are indicated as suitable for treatment of disorders in mammals that are susceptible to sodium channel blockers and antifolates, and particularly disorders such epilepsy, multiple sclerosis, glaucoma and uevitis, cerebral traumas and cerebral ischaemias, stroke, head injury, spinal cord injury, surgical trauma, neurodegenerative disorders, motorneurone disease, Alzheimer's disease, Parkinson's disease, chronic inflammatory pain, neuropathic pain, migraine, bipolar disorder, mood, anxiety and cognitive disorders, schizophrenia and trigeminal autonomic cephalalgias; for treatment of mammalian cancers; and for treatment of malaria.
    • X和Y各自为N或C,X和Y中的至少一个为N的一般结构化合物; Z是单键或任选取代的连接基团R 1是氢或取代基; R2是氨基或取代基; 当R 1为氢时,N *为氨基,或当R 1为取代基时为= NH; 或N *为NRaRb基团,其中Ra和Rb独立地为H或烷基; 或N *是任选取代的哌嗪基环; 并且A是任选取代的杂环或碳环系,其可以通过R 2与三偶氮/重氮环连接以形成稠合多环; 适用于治疗对钠通道阻滞剂和抗叶酸剂敏感的哺乳动物的疾病,特别是诸如癫痫,多发性硬化,青光眼和uev病,脑创伤和脑缺血性脑卒中,脑损伤,脊髓损伤,手术创伤 神经退行性疾病,运动​​神经元疾病,阿尔茨海默病,帕金森病,慢性炎性疼痛,神经性疼痛,偏头痛,双相情感障碍,情绪,焦虑和认知障碍,精神分裂症和三叉神经性自主性头痛。 用于治疗哺乳动物癌症; 并用于治疗疟疾。
    • 24. 发明申请
    • Methods of manufacturing engineered wood products
    • 制造工程木制品的方法
    • US20070111019A1
    • 2007-05-17
    • US11394471
    • 2006-03-31
    • Kenneth LauMichael LeachDonald Trudeau
    • Kenneth LauMichael LeachDonald Trudeau
    • B32B21/14
    • B27N1/00B27N3/002Y10T428/31982
    • Methods for manufacturing an engineered wood product are disclosed. The method includes contacting at least part of a first set of wood pieces with a first resin; contacting at least part of a second set of wood pieces with a second resin, wherein the second resin is more washout resistant than the first resin; orienting the first and second set of wood pieces to provide a blanket of oriented pieces, the blanket of oriented pieces including a core layer formed of the second set of wood pieces sandwiched between a pair of face layers formed of the first set of wood pieces; steam preheating at least a portion of the blanket of oriented pieces; and curing the first and second resins by exposing at least a part of the blanket of oriented pieces to at least one of an elevated temperature, an elevated pressure, and radiant energy.
    • 公开了制造工程木制品的方法。 该方法包括使第一组木片与第一树脂接触的至少一部分; 使第二组木片的至少一部分与第二树脂接触,其中第二树脂比第一树脂更耐冲击; 定向第一和第二组木片以提供定向片的毯子,所述定向片的毯包括由第二组木片形成的芯层,所述芯层夹在由第一组木片形成的一对面层之间; 蒸汽预热至少一部分定向片的毯子; 以及通过将取向片的至少一部分毯暴露于升高的温度,升高的压力和辐射能中的至少一个来固化所述第一和第二树脂。
    • 27. 发明授权
    • Retaining ring for wafer polishing
    • 晶圆抛光保持环
    • US06267655B1
    • 2001-07-31
    • US09116311
    • 1998-07-15
    • David E. WeldonShu-Hsin KaoMichael LeachCharles J. ReganLinh X. Can
    • David E. WeldonShu-Hsin KaoMichael LeachCharles J. ReganLinh X. Can
    • B24B722
    • B24B37/32
    • An improved wafer polishing machine is disclosed. In one embodiment, the wafer polishing machine has a movable polishing surface and a holder that holds an object, such as a semiconductor wafer, against the movable polishing surface. The holder includes a support structure that supports the object in contact with the polishing surface and an annular retaining ring that retains the object in alignment with the support structure. The retaining ring has a plurality of projections projecting inwardly from its inner circumference. The projections are evenly spaced around the inner circumference of the retaining ring. In one embodiment, the projections on the retaining ring define a circle with a diameter no less than the diameter of the object being polished. In an alternative embodiment, the retaining ring has a smooth, circular inner circumference formed from a flexible material which distends to from a continuous arc of contact with the wafer during polishing. Each retaining ring disclosed herein forms multiple points of contact or a continuous arc of contact between the retaining ring and the wafer, thereby reducing wafer buckling during polishing and improving surface uniformity.
    • 公开了一种改进的晶片抛光机。 在一个实施例中,晶片抛光机具有可动抛光表面和将诸如半导体晶片的物体保持在可动抛光表面上的保持器。 保持器包括支撑结构,其支撑与抛光表面接触的物体,以及保持对象与支撑结构对准的环形保持环。 保持环具有从其内周向内突出的多个突起。 突起围绕保持环的内圆周均匀间隔开。 在一个实施例中,保持环上的突起限定直径不小于被抛光物体的直径的圆。 在替代实施例中,保持环具有由柔性材料形成的平滑的圆形内圆周,该柔性材料在抛光期间从与晶片的连续弧接触扩展。 本文公开的每个固定环在保持环和晶片之间形成多个接触点或连续的接触弧,从而在抛光期间减少晶片屈曲并改善表面均匀性。
    • 29. 发明申请
    • CYCLIC TRIAZO AND DIAZO SODIUM CHANNEL BLOCKERS
    • 环状三唑和二氧化硅通道阻塞剂
    • US20110009413A1
    • 2011-01-13
    • US12811884
    • 2009-01-16
    • Michael LeachLaurence HarbigeDieter RiddallKarl Franzmann
    • Michael LeachLaurence HarbigeDieter RiddallKarl Franzmann
    • A61K31/53C07D253/075C07D405/04C07D403/12C07D409/04C07D253/07C07D405/14C07D401/04A61P25/08A61P25/00A61P27/06A61P25/28A61P25/16A61P25/06A61P25/18A61P25/22A61P29/00
    • C07D253/075C07D253/06C07D253/07C07D253/10C07D401/04C07D405/04C07D405/12C07D405/14C07D409/04C07D409/12
    • Compounds of general structure in which X and Y are each N or C with at least one of X and Y being N; Z is a single bond or an optionally substituted linking group R1 is hydrogen or a substituent group; R2 is amino or a substituent group; N* is amino when RI is hydrogen or ═NH when R1 is a substituent group; or N* is a group NRaRb where Ra and Rb are independently H or an alkyl group; or N* is an optionally substituted piperazinyl ring; and A is an optionally substituted heterocyclic or carbocyclic ring system which may be linked to the triazo/diazo ring through R2 to form a fused multicyclic ring; are indicated as suitable for treatment of disorders in mammals that are susceptible to sodium channel blockers and antifolates, and particularly disorders such epilepsy, multiple sclerosis, glaucoma and uevitis, cerebral traumas and cerebral ischaemias, stroke, head injury, spinal cord injury, surgical trauma, neurodegenerative disorders, motorneurone disease, Alzheimer's disease, Parkinson's disease, chronic inflammatory pain, neuropathic pain, migraine, bipolar disorder, mood, anxiety and cognitive disorders, schizophrenia and trigeminal autonomic cephalalgias; for treatment of mammalian cancers; and for treatment of malaria.
    • X和Y各自为N或C,X和Y中的至少一个为N的一般结构化合物; Z是单键或任选取代的连接基团R 1是氢或取代基; R2是氨基或取代基; 当R 1为氢时,N *为氨基,或当R 1为取代基时为= NH; 或N *为NRaRb基团,其中Ra和Rb独立地为H或烷基; 或N *是任选取代的哌嗪基环; 并且A是任选取代的杂环或碳环系,其可以通过R 2与三偶氮/重氮环连接以形成稠合多环; 适用于治疗对钠通道阻滞剂和抗叶酸剂敏感的哺乳动物的疾病,特别是诸如癫痫,多发性硬化,青光眼和uev病,脑创伤和脑缺血性脑卒中,脑损伤,脊髓损伤,手术创伤 神经退行性疾病,运动​​神经元疾病,阿尔茨海默病,帕金森病,慢性炎性疼痛,神经性疼痛,偏头痛,双相情感障碍,情绪,焦虑和认知障碍,精神分裂症和三叉神经性自主性头痛。 用于治疗哺乳动物癌症; 并用于治疗疟疾。